Press Releases

Wacker Biotech, a leading contract development and manufacturing organization (CDMO) wholly owned by Wacker Chemie AG, today announced a strategic collaboration with RNAV8 Bio, a Boston-based pioneer in mRNA engineering.

WACKER is all set to showcase several product novelties at this year’s European Coatings Show (ECS) from March 25 to 27.

Manufacturers of dry-mix mortars – in particular tile adhesives – are currently facing the challenge of adapting their formulations, which are based on Portland cement (CEM I).

With the presentation of its annual report today, Wacker Chemie AG reported that its 2024 sales and earnings fell versus the previous year due to persistently weak market conditions.

WACKER is to start replacing coal with biogenic carbon for its silicon production in Holla.